DE69934399D1 - Komplex aus peptid und mhc-peptid auf oberfläche von phagen - Google Patents

Komplex aus peptid und mhc-peptid auf oberfläche von phagen

Info

Publication number
DE69934399D1
DE69934399D1 DE69934399T DE69934399T DE69934399D1 DE 69934399 D1 DE69934399 D1 DE 69934399D1 DE 69934399 T DE69934399 T DE 69934399T DE 69934399 T DE69934399 T DE 69934399T DE 69934399 D1 DE69934399 D1 DE 69934399D1
Authority
DE
Germany
Prior art keywords
peptide
complex
mhc
concerns
micro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69934399T
Other languages
English (en)
Inventor
Guy Gorochov
Bernard Piqueras
Doussal Jean-Marc Le
Patrice Debre
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Original Assignee
Centre National de la Recherche Scientifique CNRS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS filed Critical Centre National de la Recherche Scientifique CNRS
Application granted granted Critical
Publication of DE69934399D1 publication Critical patent/DE69934399D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C12N15/73—Expression systems using phage (lambda) regulatory sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/14011—Details ssDNA Bacteriophages
    • C12N2795/14111—Inoviridae
    • C12N2795/14122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Paints Or Removers (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE69934399T 1998-05-14 1999-05-12 Komplex aus peptid und mhc-peptid auf oberfläche von phagen Expired - Lifetime DE69934399D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9806213A FR2778669B1 (fr) 1998-05-14 1998-05-14 Procede d'expression d'un complexe forme d'au moins un produit du complexe majeur d'histocompatibilite et d'un peptide chez un phage, phages et complexes ainsi obtenus et leurs applications
PCT/FR1999/001147 WO1999058693A1 (fr) 1998-05-14 1999-05-12 Complexe forme d'un peptide et d'un produit du complexe majeur d'histocompatibilite a la surface de phages

Publications (1)

Publication Number Publication Date
DE69934399D1 true DE69934399D1 (de) 2007-01-25

Family

ID=9526436

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69934399T Expired - Lifetime DE69934399D1 (de) 1998-05-14 1999-05-12 Komplex aus peptid und mhc-peptid auf oberfläche von phagen

Country Status (8)

Country Link
EP (1) EP1078078B1 (de)
JP (1) JP2002514431A (de)
AT (1) ATE348176T1 (de)
AU (1) AU3612099A (de)
CA (1) CA2331061A1 (de)
DE (1) DE69934399D1 (de)
FR (1) FR2778669B1 (de)
WO (1) WO1999058693A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1118661A1 (de) * 2000-01-13 2001-07-25 Het Nederlands Kanker Instituut T-Zellrezeptor-Bibliotheken
WO2001081624A1 (en) * 2000-04-20 2001-11-01 Virco Bvba Method for mutation detection in hiv using pol sequencing
US6800463B1 (en) * 2000-04-20 2004-10-05 Virco Bvba Method for mutation detection in HIV-1 using pol sequencing
WO2002046400A2 (en) * 2000-12-08 2002-06-13 The Board Of Trustees Of The University Of Illinois Mutated class ii major histocompatibility proteins
GB0110547D0 (en) * 2001-04-30 2001-06-20 Avidex Ltd Method

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2658197B1 (fr) * 1990-02-14 1992-05-22 Inst Nat Sante Rech Med Anticorps monoclonaux restreints reconnaissant un peptide associe a un antigene du complexe majeur d'histocompatibilite - applications au diagnostic et au traitement.
US5734023A (en) * 1991-11-19 1998-03-31 Anergen Inc. MHC class II β chain/peptide complexes useful in ameliorating deleterious immune responses
US8211422B2 (en) * 1992-03-18 2012-07-03 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Chimeric receptor genes and cells transformed therewith
DE4224542A1 (de) * 1992-07-24 1994-01-27 Deutsches Krebsforsch Verfahren zur Herstellung von monoklonalen MHC Klasse I-puls-Peptid-restringierten Antikörpern
CA2196085C (en) * 1994-07-29 2002-12-10 Hing C. Wong Mhc complexes and uses thereof
AU6331696A (en) * 1995-06-07 1996-12-30 Anergen, Inc. Fused soluble mhc heterodimer:peptide complexes and their uses
JPH11510375A (ja) * 1995-06-30 1999-09-14 コベンハブンズ ユニバーサイテッド ペプチド−ｍｈｃ複合体を指向するファージディスプレイライブラリーからの組換え抗体
US6056952A (en) * 1995-08-30 2000-05-02 The United States Of America As Represented By The Department Of Health And Human Services Selective elimination of T cells that recognize specific preselected targets
US6211342B1 (en) * 1996-07-18 2001-04-03 Children's Hospital Medical Center Multivalent MHC complex peptide fusion protein complex for stimulating specific T cell function
ES2221065T3 (es) * 1996-08-16 2004-12-16 The President And Fellows Of Harvard College Proteinas de fusion de clase ii del mhc, solubles, monovalentes o polivalentes, y sus usos.

Also Published As

Publication number Publication date
ATE348176T1 (de) 2007-01-15
FR2778669A1 (fr) 1999-11-19
FR2778669B1 (fr) 2002-06-14
AU3612099A (en) 1999-11-29
EP1078078A1 (de) 2001-02-28
WO1999058693A1 (fr) 1999-11-18
EP1078078B1 (de) 2006-12-13
CA2331061A1 (fr) 1999-11-18
JP2002514431A (ja) 2002-05-21

Similar Documents

Publication Publication Date Title
ATE368054T1 (de) Verbindungen und methoden zur modulierung von occludin-abhängiger gewebepermeabilität
PT1612265E (pt) Construções de tecidos por bioengenharia e métodos de produção e utilização das mesmas
ES2151921T3 (es) Analogo de dolastatina.
DK1053256T3 (da) Antistoffer mod Dødsreceptor 4 (DR4) og anvendelser deraf
TR199902426T2 (xx) Bitki b�ceklerinin kontrol�.
ATE295416T1 (de) Humanisiertes grünes-fluoreszenzprotein und methoden
ATE133181T1 (de) Dehydrodidemnin b
UA81398C2 (en) Keratinocytes which may be used as biologically active substances for the treatment of wounds
ATE270337T1 (de) Materialen und methoden im zusammenhang mit bindung und präsentation von substanzen auf zelloberflächen
NO20030856L (no) Membranpenetrerende peptider og anvendelse av disse
GEP20043349B (en) Methods of Controlling Cutworm Pests
FR2662698B1 (de)
ATE437951T1 (de) Intrazelluläre herstellung von verkürztem hepatitis c-polypeptid e2
IT8921243A0 (it) Nuovi geni ibridi funzionali di bacillus thuringiensis ottenuti mediante ricombinazione in vivo.
EP1077599A4 (de) Brassica-transformation durch teilchenbeschuss
DE69631972D1 (de) Proliferationsinhibitor von endothellzellen und dessen verwendung
HUP0400697A2 (hu) Elcsendesített anti-CD28 ellenanyagok és használatuk
GB9825096D0 (en) Cells,culture methods and their uses
DE69934399D1 (de) Komplex aus peptid und mhc-peptid auf oberfläche von phagen
CA2318432A1 (en) The use of isolated domains of type iv collagen to modify cell and tissue interactions
DK0939769T3 (da) Vertebrat-Smoothened-proteiner
GB2379446A (en) Cells,culture methods and their uses
DE69737597D1 (de) Vektoren zur inhibierung von viralem und tumorwachstum
DE69838615D1 (de) ppGpp-SYNTHETASE UND EXPRESSIONSSYSTEME ZUR VERBESSERTEN HERSTELLUNG VON PROTEINEN
DE60132466D1 (de) Verfahren zur kultivierung von menschlichen lungenmastzellen und deren anwendungen

Legal Events

Date Code Title Description
8332 No legal effect for de